Contents

Current Clinical Pharmacology, Volume 3 - Number 2

Validating Diagnostic Tests, Correct and Incorrect Methods, New Developments

, 3(2): 70 - 76

Ton J. Cleophas, Jolanda Droogendijk and Bas M. van Ouwerkerk


DOI: 10.2174/157488408784293697




Pioglitazone and Rosiglitazone: Effects of Treatment with a Thiazolidinedione on Lipids and Non Conventional Cardiovascular Risk Factors

, 3(2): 77 - 84

Giuseppe Derosa and Sibilla A.T. Salvadeo


DOI: 10.2174/157488408784293688




Targeted Therapies in Breast Cancer: Established Drugs and Recent Developments

, 3(2): 85 - 98

Jeanett Fischgrabe and Pia Wulfing


DOI: 10.2174/157488408784293732




Radiopharmaceuticals in Neurological and Psychiatric Disorders

, 3(2): 99 - 107

Varvara Valotassiou, Greta Wozniak, Nikolaos Sifakis, Nikolaos Demakopoulos and Panagiotis Georgoulias


DOI: 10.2174/157488408784293679




Enhancing the Cytotoxic Activity of Novel Targeted Therapies – Is There a Role for a Combinatorial Approach?

, 3(2): 108 - 117

Wai Man Liu


DOI: 10.2174/157488408784293714




Efficacy and Safety Evaluation of Fixed Dose Combination of Cefepime and Amikacin in Comparison with Cefepime Alone in Treatment of Nosocomial Pneumonia Patients

, 3(2): 118 - 122

Manu Chaudhary, Sanjay Mohan Shrivastava, Lallu Varughese and Rajesh Sehgal


DOI: 10.2174/157488408784293660




Amyloid Beta Protein and Tau in Cerebrospinal Fluid and Plasma as Biomarkers for Dementia: A Review of Recent Literature

, 3(2): 123 - 131

Suzanne V. Frankfort, Linda R. Tulner, Jos P.C.M. van Campen, Marcel M. Verbeek, Rene W.M.M. Jansen and Jos H. Beijnen


DOI: 10.2174/157488408784293723




The Molecular Basis of Class Side Effects Due to Treatment with Inhibitors of the VEGF/VEGFR Pathway

, 3(2): 132 - 143

Jeanine M. Roodhart, Marlies H. Langenberg, Els Witteveen and Emile E. Voest


DOI: 10.2174/157488408784293705




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science